These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9407819)

  • 1. Development of a policy for patients receiving neuromuscular blocking agents.
    Earl G; McMahon MB; Bartley M; Mancini W; Becker S
    J Trauma Nurs; 1997; 4(3):76-81. PubMed ID: 9407819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit.
    Rhoney DH; Murry KR
    J Intensive Care Med; 2003; 18(3):139-45. PubMed ID: 14984632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the Bispectral Index to assess arousal response in a patient with neuromuscular blockade.
    Arbour RB
    Am J Crit Care; 2000 Nov; 9(6):383-7. PubMed ID: 11072553
    [No Abstract]   [Full Text] [Related]  

  • 4. Applied pharmacology of common neuromuscular blocking agents in critical care.
    Prielipp RC; Coursin DB
    New Horiz; 1994 Feb; 2(1):34-47. PubMed ID: 7922428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular blockade: indications, peripheral nerve stimulation, and other concurrent interventions.
    Davidson JE
    New Horiz; 1994 Feb; 2(1):75-84. PubMed ID: 7922432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular blockade in adult intensive care.
    Topulos GP
    New Horiz; 1993 Aug; 1(3):447-62. PubMed ID: 7922424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
    Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
    Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sedative use in patients receiving neuromuscular blocking agents from a helicopter flight team.
    Frakes MA; Lord WR
    Air Med J; 2006; 25(4):173-5. PubMed ID: 16818168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nursing care of patients receiving long-term infusion of neuromuscular blocking agents.
    Jarpe MB
    Crit Care Nurse; 1992 Oct; 12(7):58-63. PubMed ID: 1478105
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuromuscular blockade: when paralysis is intentional.
    Reichenbach SL
    RN; 1995 Jun; 58(6):42-8; quiz 49. PubMed ID: 7792511
    [No Abstract]   [Full Text] [Related]  

  • 11. Train-of-four results and observed muscle movement in children during continuous neuromuscular blockade.
    Corso L
    Crit Care Nurse; 2008 Jun; 28(3):30-8; quiz 39. PubMed ID: 18515606
    [No Abstract]   [Full Text] [Related]  

  • 12. Monitoring neuromuscular blockade in the intensive care unit: the peripheral nerve stimulator.
    Rowlee SC
    Heart Lung; 1999; 28(5):352-62; quiz 363-4. PubMed ID: 10486453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent paralysis in critically ill patients after the use of neuromuscular blocking agents.
    Hoyt JW
    New Horiz; 1994 Feb; 2(1):48-55. PubMed ID: 7922429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral electrical stimulation: titrating neuromuscular blocking agent levels.
    Hill L
    Dimens Crit Care Nurs; 1995; 14(6):305-14. PubMed ID: 8631213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved neuromuscular blockade using a novel neuromuscular blockade advisory system: a randomized, controlled, clinical trial.
    Gilhuly TJ; Macleod BA; Dumont GA; Bouzane AM; Schwarz SK
    Anesth Analg; 2008 Nov; 107(5):1609-17. PubMed ID: 18931219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular blocking agents in critical care.
    Susla GM
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):297-311. PubMed ID: 8398037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of peripheral nerve stimulators to monitor patients with neuromuscular blockade in the ICU.
    Kleinpell R; Bedrosian C; McCormick L; Kremer M; Bujalski L; Bronsted R
    Am J Crit Care; 1996 Nov; 5(6):449-54. PubMed ID: 8922161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve stimulation in the setting of pharmacologic blockade.
    Villars PS
    Crit Care Nurse; 2008 Oct; 28(5):24; author reply 24. PubMed ID: 18827084
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of neuromuscular blockade in the critically ill patient.
    Burry L; HoSang M; Hynes-Gay P
    Dynamics; 2001; 12(3):28-33; quiz 34-5. PubMed ID: 11982205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should ICU patients receive muscle relaxants?
    Coakley J
    Schweiz Med Wochenschr; 1996 Sep; 126(39):1644-8. PubMed ID: 8858758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.